Quizartinib is a Good Option for AML Patients with FLT3-ITD Mutations
The Innovation Medicine（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined